EirGenix Inc.

NT$46.90As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6589Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 1.98%
Div yield —
ROE (7.00%)
Biotechnology
Beta (5Y) 0.36
PE TTM —
TSR TTM (30.00%)
Mkt cap NT$14.01B
ROIC (13.09%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$56
20.01%
(56.96%)
Hold 12|1|9|4|7
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.85
0.82
0.86
0.89
(10.21%)
(12.20%)
(5.07%)
(0.06%)
RevenueNT$B
1.556
1.586
1.626
1.703
4.01%
3.50%
7.24%
13.63%
Peers (US$423.0M)
Cap (US$)
PE
439.6M
29.51x
422.9M
1,362x
Capital
TTM
5Y
10Y
Leveragex
0.424
1.960
1.402
EBIT/Intx
2.934
0.564
0.598
Own earn%
9.01
11.03
6.61
Sh yield%
29.78
22.38
25.01
Owners
Insiders/Inst%
12.33
28.61
Short interest%
4.89
SBC / revenue%
3.97
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
5–11
$1 testx
−0.2
Incr. ROIC%
3